The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine

被引:5
|
作者
Nishiyama-Fujita, Yuriko [1 ]
Nakazato, Tomonori [1 ]
Kamiya, Takahiro [1 ]
Mizuno, Kota [1 ]
Ito, Chisako [1 ]
Ogura, Shinji [1 ]
Sakurai, Aki [1 ]
Tanigawa, Tomohiko [1 ]
Akimoto, Masahiro [1 ]
Aisa, Yoshinobu [1 ]
机构
[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Yokohama, Kanagawa, Japan
关键词
D O I
10.1002/hon.2760
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:611 / 613
页数:3
相关论文
共 50 条
  • [21] Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis
    Craig, Jeffrey W.
    Hasserjian, Robert P.
    Kim, Annette S.
    Aster, Jon C.
    Pinkus, Geraldine S.
    Hornick, Jason L.
    Steensma, David P.
    Lindsley, R. Coleman
    DeAngelo, Daniel J.
    Morgan, Elizabeth A.
    MODERN PATHOLOGY, 2020, 33 (06) : 1135 - 1145
  • [22] Case report: Positive response to venetoclax and azacitidine in the treatment of acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype
    Wen, Xiaojia
    Yu, Jiaole
    Fan, Jia
    Zhu, Shuai
    Zheng, Huyong
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
  • [23] Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes
    Wan, Yang
    Zhang, Ranran
    Ruan, Min
    Li, Jun
    Li, Xiaolan
    Zhang, Xiaoyan
    Chen, Xiaojuan
    Zhang, Li
    Zou, Yao
    Chen, Yumei
    Guo, Ye
    Yang, Wenyu
    Zhu, Xiaofan
    BLOOD, 2022, 140 : 11628 - 11629
  • [24] Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC)
    Parmawati, Ni Komang Ayu
    Herawati, Sianny
    Wande, I. Nyoman
    BALI MEDICAL JOURNAL, 2019, 8 (02) : 358 - 362
  • [25] Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome
    Narayan, Rupa
    Garcia, Jacqueline S.
    Percival, Mary-Elizabeth M.
    Berube, Caroline
    Coutre, Steve
    Gotlib, Jason
    Greenberg, Peter
    Liedtke, Michaela
    Hewitt, Rhonda
    Regan, Kathleen
    Williamson, Charles
    Doykan, Camille
    Cardone, Michael H.
    McMillan, Alex
    Medeiros, Bruno C.
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 609 - 615
  • [26] IMPACT OF MYELODYSPLASIA-RELATED CHANGES AS DEFINED BY THE 2008 WHO CLASSIFICATION SYSTEM IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED INTENSIVELY
    Gardin, C.
    Terre, C.
    Gachard, N.
    Tigaud, I.
    Desangles, F.
    Bastard, C.
    Maarek, O.
    Lai, J. -L.
    Bernheim, A.
    Perot, C.
    Eclache, V.
    Turlure, P.
    Thomas, X.
    Castaigne, S.
    Michallet, M.
    Preudhomme, C.
    Fagot, T.
    Bordessoule, D.
    Fenaux, P.
    Dombret, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 340 - 340
  • [27] Frequency, Clinical Associations, and Prognostic Significance Of Spliceosome Mutations In Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid Leukemia
    Cho, Young-Uk
    Chi, Hyun-Sook
    Park, Sang Hyuk
    Kim, Young Jin
    Jang, Seongsoo
    Seo, Eul-Ju
    Park, Chan-Jeoung
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    Koh, Kyung Nam
    Im, Ho Joon
    Seo, Jong Jin
    Park, Young-Mi
    Lee, Jong-Keuk
    BLOOD, 2013, 122 (21)
  • [28] Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
    John F. Seymour
    Hartmut Döhner
    Aleksandra Butrym
    Agnieszka Wierzbowska
    Dominik Selleslag
    Jun Ho Jang
    Rajat Kumar
    James Cavenagh
    Andre C. Schuh
    Anna Candoni
    Christian Récher
    Irwindeep Sandhu
    Teresa Bernal del Castillo
    Haifa Kathrin Al-Ali
    Jose Falantes
    Richard M. Stone
    Mark D. Minden
    Jerry Weaver
    Steve Songer
    C. L. Beach
    Hervé Dombret
    BMC Cancer, 17
  • [29] MYELODYSPLASTIC SYNDROME RELATED CYTOGENETIC ABNORMALITIES DO NOT HAVE NEGATIVE IMPACT ON SURVIVAL AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC)
    Yuasa, M.
    Uchida, N.
    Kaji, D.
    Ota, H.
    Ishiwata, K.
    Tsuji, M.
    Yamamoto, H.
    Yamamoto, G.
    Asano-Mori, Y.
    Maikino, S.
    Yoneyama, A.
    Masuoka, K.
    Wake, A.
    Izutsu, K.
    Taniguchi, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S114 - S114
  • [30] Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
    Seymour, John F.
    Doehner, Hartmut
    Butrym, Aleksandra
    Wierzbowska, Agnieszka
    Selleslag, Dominik
    Jang, Jun Ho
    Kumar, Rajat
    Cavenagh, James
    Schuh, Andre C.
    Candoni, Anna
    Recher, Christian
    Sandhu, Irwindeep
    del Castillo, Teresa Bernal
    Al-Ali, Haifa Kathrin
    Falantes, Jose
    Stone, Richard M.
    Minden, Mark D.
    Weaver, Jerry
    Songer, Steve
    Beach, C. L.
    Dombret, Herve
    BMC CANCER, 2017, 17